# FDA Inspection 1265860 - NextPharma Ploermel - October 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/nextpharma-ploermel/369f6d47-e314-4285-afa3-e9268ae4e8f6
Source feed: FDA_Inspections

> FDA Inspection 1265860 for NextPharma Ploermel on October 27, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265860
- Company Name: NextPharma Ploermel
- Inspection Date: 2023-10-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1093157 - 2018-04-20](https://www.keypedia.com/records/fda_inspections/nextpharma-ploermel/9779f40a-014f-430e-b54a-462727a5510c)
- [FDA Inspection 913247 - 2015-01-30](https://www.keypedia.com/records/fda_inspections/nextpharma-ploermel/a789432a-983d-4c7f-ae3f-e4730bbb2979)
- [FDA Inspection 650243 - 2010-02-17](https://www.keypedia.com/records/fda_inspections/nextpharma-ploermel/2ccee391-037a-4ed2-8087-1c026659f097)

Company: https://www.keypedia.com/companies/nextpharma-ploermel/abfc25a0-dc7c-4ed0-9b93-b92237708de9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c